Steven Engle is a Senior Principal Scientist at Eli Lilly and Company, where they have focused on the development and application of in vitro screening tools for safety assessment. Previously, they worked as a Consultant Toxicologist, Associate Consultant Toxicologist, and Associate Biologist at Eli Lilly, contributing to drug safety and portfolio risk assessment. Engle also served as a Research Associate at the Indiana University School of Medicine and as Chair/Co-Chair for the Predictive Safety Testing Consortium's Cardiac Hypertrophy Working Group. They hold a Master’s degree in Biology from Indiana University Indianapolis and a Bachelor of Science in Molecular Biology from Vanderbilt University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices